Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients

Clinical and Vaccine Immunology

Volumn 15, Issue 10, 2008, Pages 1564-1571

  Randhawa, P ^a,e   Bohl, D ^c   Brennan, D ^c   Ruppert, K ^a   Ramaswami, B ^a   Storch, G ^c   March, J ^a   Shapiro, R ^b   Viscidi, R ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA; DIAGNOSTIC AGENT; VIROSOME; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BK VIRUS; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY GRAFT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RECIPIENT; SEROCONVERSION; URINALYSIS; VIREMIA; VIRURIA; VIRUS CAPSID; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION; BLOOD; EVALUATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; URINE; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; BK VIRUS; CAPSID PROTEINS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; VIREMIA; VIROSOMES;

EID: 55449094163     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00206-08     Document Type: Article

References (53)

1. Agha, I. A., K. L. Hardinger, D. Bohl, A. Ansari, P. Dyk, M. Koch, B. Miller, M. Jendrisak, S. Shenoy, N. Desai, D. Beffa, J. Lowell, M. Schnitzler, G. Storch, and D. C. Brennan. 2004. Preemptive withdrawal of AZA or MMF prevents progression of BK viremia to BK nephropathy: a prospective randomized controlled trial of BK virus infection after renal transplantation. Am. J. Transplant. 4:200.
2. Amor, A., C. Toro, V. Jimenez, A. Simon, B. Ramos, and V. Soriano. 2006. Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART. AIDS 20:1460-1462.
3. Bodeus, M., F. Smets, R. Reding, E. Sokal, J. B. Otte, P. Goubau, and L. van Renterghem. 1999. Epstein-Barr virus infection in sixty pediatric liver graft recipients: diagnosis of primary infection and virologic follow-up. Pediatr. Infect. Dis. J. 18:698-702.
4. Bohl, D. L., C. Ryschkewitsch, E. O. Major, G. A. Storch, and D. C. Brennan. 2005. BK virus antibody titers markedly increase with viremia. Am. J. Transplant. 5:273.
5. Bohl, D. L., G. Storch, C. Ryschkewitsch, M. Gaudreault-Keener, M. Schnitzler, E. O. Major, and D. C. Brennan. 2005. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am. J. Transplant. 5:2213-2221.
6. Brennan, D. C., I. Agha, D. L. Bohl, M. A. Schnitzler, H. L. Hardinger, M. Lockwood, S. Torrence, R. Schuessler, T. Roby, M. Gaudreault-Keener, and G. A. Storch. 2005. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am. J. Transplant. 5:582-594.
7. Cesaro, S., C. Facchin, G. Tridello, C. Messina, E. Calore, M. A. Biasolo, M. Pillon, S. Varotto, A. Brugiolo, C. Mengoli, and G. Palu. 2008. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 41:363-370.
8. Chatterjee, S. N., M. Fiala, J. Weiner, J. A. Stewart, B. Stacey, and N. Warmer. 1978. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA 240:2446-2449.
9. Conti, D. J., B. M. Freed, S. A. Gruber, and N. Lempert. 1994. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch. Surg. 129:443-447.
10. Cubukcu-Dimopulo, O., A. Greco, A. Kumar, D. Karluk, K. Mittal, and J. Jagirdar. 2000. BK virus infection in AIDS. Am. J. Surg. Pathol. 24:145-149.
11. Demeter, L. M. 1995. JC, BK, and other polyomaviruses: progressive multifocal leukoencephalopathy, p. 1400-1406. In G. L. Mandel, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, NY.
12. De Stasio, A., P. Mastromarino, A. Pana, L. Seganti, S. Sinibaldi, P. Valenti, and N. Orsi. 1980. Characterization of a glycoprotein inhibitor present in human serum and active towards BK virus hemagglutination. Microbiologica 3:293-305.
13. De Stasio, A., N. Orsi, A. Pana, L. Seganti, S. Sinibaldi, and P. Valenti. 1979. The importance of pre-treatment of human sera for the titration of hemagglutination-inhibiting antibodies towards BK virus. Ann. Sclavo 21:249-257.
14. Drachenberg, C. B., C. O. Beskow, C. B. Cangro, P. M. Bourquin, A. Simsir, J. Fink, M. R. Weir, D. K. Klassen, S. T. Bartlett, and J. C. Papadimitriou. 1999. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum. Pathol. 30:970-977.
15. Drachenberg, C. B., J. C. Papadimitriou, R. Wali, C. L. Cubitt, and E. Ramos. 2003. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am. J. Transplant. 3:1383-1392.
16. Drachenberg, R. C., C. B. Drachenberg, J. C. Papadimitriou, E. Ramos, J. C. Fink, R. Wali, M. R. Weir, C. B. Cangro, D. K. Klassen, A. Khaled, R. Cunningham, and S. T. Bartlett. 2001. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am. J. Transplant. 1:373-381.
17. Flower, A. J., J. E. Banatvala, and I. L. Chrystie. 1977. BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br. Med. J. 2(6081):220-223.
18. Gardner, S. D., A. M. Field, D. V. Coleman, and B. Hulme. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet i:1253-1257.
19. Gardner, S. D., E. F. MacKenzie, C. Smith, and A. A. Porter. 1984. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J. Clin. Pathol. 37:578-586.
20. Ginevri, F., A. Azzi, H. H. Hirsch, S. Basso, I. Fontana, M. Cioni, S. Bodaghi, V. Salotti, A. Rinieri, G. Botti, F. Perfumo, F. Locatelli, and P. Comoli. 2007. Prospective monitoring of polyomavirus BK replication and impact of preemptive intervention in pediatric kidney recipients. Am. J. Transplant. 7:2727-2735.
21. Ginevri, F., R. De Santis, P. Comoli, N. Pastorino, C. Rossi, G. Botti, I. Fontana, A. Nocera, M. Cardillo, M. R. Ciardi, F. Locatelli, R. Maccario, F. Perfumo, A. Azzi, L. Haysom, A. R. Rosenberg, G. Kainer, Z. M. Waliuzzaman, J. Roberts, W. D. Rawlinson, F. E. Mackie, J. Herman, M. Van Ranst, R. Snoeck, K. Beuselinck, E. Lerut, R. Van Damme-Lombaerts, S. Basso, A. Moretta, F. Del Galdo, R. De Palma, and U. Valente. 2003. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 75:1266-1270.
22. Hamilton, R. S., M. Gravell, and E. O. Major. 2000. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J. Clin. Microbiol. 38:105-109.
23. Hariharan, S., E. P. Cohen, B. Vasudev, R. Orentas, R. P. Viscidi, J. Kakela, and B. DuChateau. 2005. BK virus specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am. J. Transplant. 5:2719-2724.
24. Hart, M., A. Steel, S. A. Clark, G. Moyle, M. Nelson, D. C. Henderson, R. Wilson, F. Gotch, B. Gazzard, and P. Kelleher. 2007. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J. Immunol. 178:8212-8220.
25. Henle, W., and G. Henle. 1981. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res. 41:4222-4225.
26. Hirsch, H. H., W. Knowles, M. Dickenmann, J. Passweg, T. Klimkait, M. J. Mihatsch, and J. Steiger. 2002. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 347:488-496.
27. Hirsch, H. H., M. Mohaupt, and T. Klimkait. 2001. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J. Infect. Dis. 184:1494-1495.
28. Hogan, T. F., E. C. Borden, J. A. McBain, B. L. Padgett, and D. L. Walker. 1980. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann. Intern. Med. 92:373-378.
29. Kassutto, S., M. N. Johnston, and E. S. Rosenberg. 2005. Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Clin. Infect. Dis. 40:868-873.
30. Khoury, J. A., G. A. Storch, D. L. Bohl, R. M. Schuessler, S. M. Torrence, M. Lockwood, M. Gaudreault-Keener, M. J. Koch, B. W. Miller, K. L. Hardinger, M. A. Schnitzler, and D. C. Brennan. 2006. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am. J. Transplant. 6:2134-2143.
31. Knowles, W. A., P. Pipkin, N. Andrews, A. Vyse, P. Minor, D. W. Brown, and E. Miller. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71:115-123.
32. Lefrere, J. J., S. Guiramand, F. Lefrere, M. Mariotti, P. Aumont, J. Lerable, J. C. Petit, R. Girot, and L. Morand-Joubert. 1997. Full or partial seroreversion in patients infected by hepatitis C virus. J. Infect. Dis. 175:316-322.
33. Lok, A. S. F., D. Chien, Q. L. Choo, T. M. Chan, E. K. W. Chiu, I. K. P. Cheng, M. Houghton, and G. Kuo. 1993. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18:497-502.
34. Mylonakis, E., N. Goes, R. H. Rubin, A. B. Cosimi, R. B. Colvin, and J. A. Fishman. 2001. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 72:1587-1592.
35. Nickeleit, V., H. H. Hirsch, I. F. Binet, F. Gudat, O. Prince, P. Dalquen, G. Thiel, and M. J. Mihatsch. 1999. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J. Am. Soc. Nephrol. 10:1080-1089.
36. Nickeleit, V., T. Klimkait, I. F. Binet, P. Dalquen, V. Del Zenero, G. Thiel, M. J. Mihatsch, and H. H. Hirsch. 2000. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N. Engl. J. Med. 342:1309-1315.
37. Noss, G. 1987. Human polyoma virus type BK infection and T antibody response in renal transplant recipients. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 266:567-574.
38. Ragni, M. V., O. K. Ndimbie, E. O. Rice, F. A. Bontempo, and S. Nedjar. 1993. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion". Blood 82:1010-1015.
39. Ramos, E., C. B. Drachenberg, J. C. Papadimitriou, O. Hamze, J. C. Fink, D. K. Klassen, R. C. Drachenberg, A. Wiland, R. Wali, C. B. Cangro, E. Schweitzer, S. T. Bartlett, and M. R. Weir. 2002. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J. Am. Soc. Nephrol. 13:2145-2151.
40. Randhawa, P. S., and A. J. Demetris. 2000. Nephropathy due to polyomavirus type BK. N. Engl. J. Med. 342:1361-1363.
41. Randhawa, P. S., S. Finkelstein, V. Scantlebury, R. Shapiro, C. Vivas, M. Jordan, M. M. Pickin, and A. J. Demetris. 1999. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67:103-109.
42. Randhawa, P. S., G. Gupta, A. Vats, R. Shapiro, and R. P. Viscidi. 2006. Immunoglobulin G, A, andMresponses to BK virus in renal transplantation. Clin. Vaccine Immunol. 13:1057-1063.
43. Randhawa, P. S., A. Vats, R. Shapiro, K. Weck, and V. Scantlebury. 2002. BK virus: discovery, epidemiology, and biology. Graft 5(Suppl.):S19-S27.
44. Razonable, R. R., R. A. Brown, A. Humar, E. Covington, E. Alecock, and C. V. Paya. 2005. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J. Infect. Dis. 192:1349-1354.
45. Rosen, S., W. Harmon, A. M. Krensky, P. J. Edelson, B. L. Padgett, B. W. Grinnell, M. J. Rubino, and D. L. Walker. 1983. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N. Engl. J. Med. 308:1192-1196.
46. Shah, G. J., A. J. Demetris, J. S. Gavaler, J. H. Lewis, S. Todo, T. E. Starzl, and D. H. Vanthiel. 1992. Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 103:323-329.
47. Shah, K., R. Daniel, D. Madden, and S. Stagno. 1980. Serological investigation of BK papovavirus infection in pregnant women and their offspring. Infect. Immun. 30:29-35.
48. Smets, F., P. Bodeus, R. Goubau, R. Reding, J. B. Otte, J. P. Buts, and E. M. Sokal. 2000. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients. J. Hepatol. 32:100-104.
49. Smith, J. M., L. Corey, P. J. Healey, C. L. Davis, and R. A. McDonald. 2007. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients. Transplantation 83:1423-1428.
50. Smith, J. M., R. A. McDonald, L. S. Finn, P. J. Healey, C. L. Davis, and A. P. Limaye. 2004. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am. J. Transplant. 4:2109-2117.
51. Vallbracht, A., J. Lohler, J. Gossmann, T. Gluck, D. Petersen, H. J. Gerth, M. Gencic, and K. Dorries. 1993. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am. J. Pathol. 143:29-39.
52. Wong, A. S., K. H. Chan, V. C. Cheng, K. Y. Yuen, Y. L. Kwong, and A. Y. Leung. 2007. Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin. Infect. Dis. 44:830-837.
53. Zangwill, S. D., D. T. Hsu, M. R. Kichuk, J. H. Garvin, C. J. Stolar, J. Haddad, Jr., S. Stylianos, R. E. Michler, A. Chadburn, D. M. Knowles, and L. J. Addonizio. 1998. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J. Heart Lung Transplant. 17:1161-1166.